Search: WFRF:(Murray Susan) > Economic Evaluation...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 07072naa a2200865 4500 | |
001 | oai:lup.lub.lu.se:4bc2d2f9-cd54-4208-886f-54632a143b8c | |
003 | SwePub | |
008 | 210115s2020 | |||||||||||000 ||eng| | |
009 | oai:prod.swepub.kib.ki.se:145197471 | |
024 | 7 | a https://lup.lub.lu.se/record/4bc2d2f9-cd54-4208-886f-54632a143b8c2 URI |
024 | 7 | a https://doi.org/10.1002/acr.240922 DOI |
024 | 7 | a http://kipublications.ki.se/Default.aspx?queryparsed=id:1451974712 URI |
040 | a (SwePub)lud (SwePub)ki | |
041 | a engb eng | |
042 | 9 SwePub | |
072 | 7 | a art2 swepub-publicationtype |
072 | 7 | a ref2 swepub-contenttype |
100 | 1 | a Barber, Megan R.W.u University of Calgary4 aut |
245 | 1 0 | a Economic Evaluation of Damage Accrual in an International Systemic Lupus Erythematosus Inception Cohort Using a Multistate Model Approach |
264 | c 2020-11-27 | |
264 | 1 | b Wiley,c 2020 |
300 | a 9 s. | |
520 | a Objective: There is a paucity of data regarding health care costs associated with damage accrual in systemic lupus erythematosus. The present study was undertaken to describe costs associated with damage states across the disease course using multistate modeling. Methods: Patients from 33 centers in 11 countries were enrolled in the Systemic Lupus International Collaborating Clinics (SLICC) inception cohort within 15 months of diagnosis. Annual data on demographics, disease activity, damage (SLICC/American College of Rheumatology Damage Index [SDI]), hospitalizations, medications, dialysis, and selected procedures were collected. Ten-year cumulative costs (Canadian dollars) were estimated by multiplying annual costs associated with each SDI state by the expected state duration using a multistate model. Results: A total of 1,687 patients participated; 88.7% were female, 49.0% were white, mean ± SD age at diagnosis was 34.6 ± 13.3 years, and mean time to follow-up was 8.9 years (range 0.6–18.5 years). Mean annual costs were higher for those with higher SDI scores as follows: $22,006 (Canadian) (95% confidence interval [95% CI] $16,662, $27,350) for SDI scores ≥5 versus $1,833 (95% CI $1,134, $2,532) for SDI scores of 0. Similarly, 10-year cumulative costs were higher for those with higher SDI scores at the beginning of the 10-year interval as follows: $189,073 (Canadian) (95% CI $142,318, $235,827) for SDI scores ≥5 versus $21,713 (95% CI $13,639, $29,788) for SDI scores of 0. Conclusion: Patients with the highest SDI scores incur 10-year cumulative costs that are ~9-fold higher than those with the lowest SDI scores. By estimating the damage trajectory and incorporating annual costs, data on damage can be used to estimate future costs, which is critical knowledge for evaluating the cost-effectiveness of novel therapies. | |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Reumatologi och inflammation0 (SwePub)302102 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Rheumatology and Autoimmunity0 (SwePub)302102 hsv//eng |
700 | 1 | a Hanly, John G.u Dalhousie University4 aut |
700 | 1 | a Su, Liu University of Cambridge4 aut |
700 | 1 | a Urowitz, Murray B.u University of Toronto4 aut |
700 | 1 | a St. Pierre, Yvan4 aut |
700 | 1 | a Romero-Diaz, Juanitau Instituto Nacional de Ciencias Médicas y Nutrición4 aut |
700 | 1 | a Gordon, Carolineu University of Birmingham4 aut |
700 | 1 | a Bae, Sang Cheolu Hanyang University4 aut |
700 | 1 | a Bernatsky, Sashau McGill University Health Center4 aut |
700 | 1 | a Wallace, Daniel J.u Cedars-Sinai Medical Center4 aut |
700 | 1 | a Merrill, Joan T.u Oklahoma Medical Research Foundation4 aut |
700 | 1 | a Isenberg, David A.u University College London4 aut |
700 | 1 | a Rahman, Anisuru University College London4 aut |
700 | 1 | a Ginzler, Ellen M.u SUNY Downstate Health Sciences University4 aut |
700 | 1 | a Petri, Michelleu Johns Hopkins University School of Medicine4 aut |
700 | 1 | a Bruce, Ian N.u Manchester Academic Health Science Centre4 aut |
700 | 1 | a Dooley, Mary A.u University of North Carolina4 aut |
700 | 1 | a Fortin, Paul R.u Laval University4 aut |
700 | 1 | a Gladman, Dafna D.u University of Toronto4 aut |
700 | 1 | a Sanchez-Guerrero, Jorgeu University of Toronto4 aut |
700 | 1 | a Steinsson, Kristjanu National University Hospital of Iceland4 aut |
700 | 1 | a Ramsey-Goldman, Rosalindu Northwestern University4 aut |
700 | 1 | a Khamashta, Munther A.4 aut |
700 | 1 | a Aranow, Cynthiau Feinstein Institutes for Medical Research4 aut |
700 | 1 | a Mackay, Megganu Feinstein Institutes for Medical Research4 aut |
700 | 1 | a Alarcón, Graciela S.u University of Alabama4 aut |
700 | 1 | a Manzi, Susanu University of Pittsburgh4 aut |
700 | 1 | a Nived, Olau Lund University,Lunds universitet,Reumatologi och molekylär skelettbiologi,Sektion III,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Rheumatology,Section III,Department of Clinical Sciences, Lund,Faculty of Medicine4 aut0 (Swepub:lu)reum-oni |
700 | 1 | a Jönsen, Andreasu Lund University,Lunds universitet,Reumatologi och molekylär skelettbiologi,Sektion III,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Lund SLE Research Group,Forskargrupper vid Lunds universitet,Rheumatology,Section III,Department of Clinical Sciences, Lund,Faculty of Medicine,Lund University Research Groups4 aut0 (Swepub:lu)reum-ajo |
700 | 1 | a Zoma, Asad A.u Hairmyres Hospital4 aut |
700 | 1 | a van Vollenhoven, Ronald F.u Karolinska Institutet4 aut |
700 | 1 | a Ramos-Casals, Manuelu Hospital Clínic of Barcelona4 aut |
700 | 1 | a Ruiz-Irastorza, Guillermou Hospital de Cruces4 aut |
700 | 1 | a Lim, S. Samu Emory University4 aut |
700 | 1 | a Kalunian, Kenneth C.u University of California, Los Angeles4 aut |
700 | 1 | a Inanc, Muratu Istanbul University4 aut |
700 | 1 | a Kamen, Diane L.u Medical University of South Carolina4 aut |
700 | 1 | a Peschken, Christine A.u University of Manitoba4 aut |
700 | 1 | a Jacobsen, Sørenu Copenhagen University Hospital4 aut |
700 | 1 | a Askanase, Ancau Indian Institute of Technology4 aut |
700 | 1 | a Farewell, Vernonu University of Cambridge4 aut |
700 | 1 | a Stoll, Thomas4 aut |
700 | 1 | a Buyon, Jillu New York University4 aut |
700 | 1 | a Clarke, Ann E.u University of Calgary4 aut |
710 | 2 | a University of Calgaryb Dalhousie University4 org |
773 | 0 | t Arthritis Care and Researchd : Wileyg 72:12, s. 1800-1808q 72:12<1800-1808x 2151-464Xx 2151-4658 |
856 | 4 | u http://dx.doi.org/10.1002/acr.24092y FULLTEXT |
856 | 4 | u http://pure-oai.bham.ac.uk/ws/files/77244747/Barber_et_al_Economic_evaluation_of_damage_accrual_in_an_international_SLE_inception_cohort_using_a_multi_state_model_approach_Arthritis_Care_Research_2019.pdf |
856 | 4 8 | u https://lup.lub.lu.se/record/4bc2d2f9-cd54-4208-886f-54632a143b8c |
856 | 4 8 | u https://doi.org/10.1002/acr.24092 |
856 | 4 8 | u http://kipublications.ki.se/Default.aspx?queryparsed=id:145197471 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.